RENAISSANCE TECHNOLOGIES LLC
Position in NAUT — Nautilus Biotechnology, Inc.
CIK 1037389
NEW YORK, NY
Position in NAUT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,291,261
+$260,345 QoQ
Shares Held
690,514
+159.9% QoQ
Ownership
0.543%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 93 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAUT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,579,858 across 312 Biotechnology names. NAUT ranks #164 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in NAUT
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,291,261 | 690,514 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,030,916 | 265,700 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $506,805 | 259,900 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $851,474 | 1,007,662 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $449,431 | 619,906 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $258,692 | 300,456 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $420,371 | 250,221 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $440,895 | 154,700 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $327,834 | 140,100 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $370,440 | 126,000 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $348,933 | 116,700 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $369,088 | 116,800 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $450,468 | 116,400 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $305,254 | 110,200 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $179,100 | 99,500 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $188,892 | 89,100 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $171,084 | 63,600 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $47,740 | 11,000 | Shares | Sole | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||